Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury
- PMID: 20176685
- DOI: 10.1124/jpet.110.165605
Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury
Abstract
Several lines of evidence suggest a biological role for peroxisome proliferator-activated receptor (PPAR)-beta/delta in the pathogenesis many diseases. The aim of the present study was to evaluate the contribution of PPAR-beta/delta in the secondary damage in experimental spinal cord injury (SCI) in mice. To this purpose, we used 4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid (GW0742), a high-affinity PPAR-beta/delta agonist. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5 to T8 laminectomy. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of inflammatory mediators, tissue damage, and apoptosis. GW0742 treatment (0.3 mg kg(-1) i.p.) 1 and 6 h after the SCI significantly reduced 1) the degree of spinal cord inflammation and tissue injury (histological score), 2) neutrophil infiltration (myeloperoxidase activity), 3) nitrotyrosine formation, 4) proinflammatory cytokines expression, 5) nuclear factor-kappaB activation, 6) inducible nitric-oxide synthase expression, and 6) apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, FasL, Bax, and Bcl-2 expression). Moreover, GW0742 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). To elucidate whether the protective effects of GW0742 are related to activation of the PPAR-beta/delta receptor, we also investigated the effect of PPAR-beta/delta antagonist methyl 3-({[2-(methoxy)-4 phenyl]amino}sulfonyl)-2-thiophenecarboxylate (GSK0660) on the protective effects of GW0742. GSK0660 (1 mg/kg i.p. 30 min before treatment with GW0742) significantly blocked the effect of the PPAR-beta/delta agonist and thus abolished the protective effect. Our results clearly demonstrate that GW0742 treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.
Similar articles
-
Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.Invest Ophthalmol Vis Sci. 2013 Jun 19;54(6):4197-207. doi: 10.1167/iovs.13-11608. Invest Ophthalmol Vis Sci. 2013. PMID: 23716627 Free PMC article.
-
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.Shock. 2008 Aug;30(2):142-52. doi: 10.1097/SHK.0b013e31815dd381. Shock. 2008. PMID: 18628687
-
Role of PPAR-β/δ/miR-17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic-ischemic injury in rats.Neuropharmacology. 2018 Sep 15;140:150-161. doi: 10.1016/j.neuropharm.2018.08.003. Epub 2018 Aug 4. Neuropharmacology. 2018. PMID: 30086290 Free PMC article.
-
Protective role of peroxisome proliferator-activated receptor-β/δ against pulmonary oxygen toxicity mediated through changes in NOS expression levels.Exp Lung Res. 2014 Apr;40(3):105-16. doi: 10.3109/01902148.2013.879497. Exp Lung Res. 2014. PMID: 24624894
-
Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.J Hypertens. 2015 Sep;33(9):1831-44. doi: 10.1097/HJH.0000000000000634. J Hypertens. 2015. PMID: 26147382
Cited by
-
Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling.Cell Tissue Res. 2012 Jul;349(1):201-13. doi: 10.1007/s00441-012-1425-5. Epub 2012 May 17. Cell Tissue Res. 2012. PMID: 22592625 Free PMC article. Review.
-
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.J Neuroinflammation. 2013 Feb 1;10:20. doi: 10.1186/1742-2094-10-20. J Neuroinflammation. 2013. PMID: 23374874 Free PMC article.
-
Hippocampal PPARδ Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis.Int J Neuropsychopharmacol. 2015 Sep 10;19(1):pyv083. doi: 10.1093/ijnp/pyv083. Int J Neuropsychopharmacol. 2015. PMID: 26362775 Free PMC article.
-
Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy.Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):483-98. doi: 10.1007/s10096-010-1122-9. Epub 2010 Dec 9. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21140187 Review.
-
Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Cancer Metastasis Rev. 2011 Dec;30(3-4):619-40. doi: 10.1007/s10555-011-9320-1. Cancer Metastasis Rev. 2011. PMID: 22037942 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials